Market data loadingS&P 500--NASDAQ--Data as of latest ETNo timestamp

CareDx, Inc. (CDNA) Guidance & Earnings Results

On 2026-07-30 CareDx, Inc. raised guidance: "FY26 revenue raised to $490-500M from $447-465M; FY26 AEBITDA raised to $66-78M from…" — from its own filing, as read by EquiReason.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

CDNACareDx, Inc.Follow CDNA — free
Diagnostics & Research · Healthcare
—
Price chart with a free account
Market cap
3.6B
P/E TTM
33.4
Dividend yield
—
52-week
—
Next earnings
29 Oct, in 5 days

What management guided

each earnings 8-K · figures checked against the filing text
ReleaseDirectionWhat they said
30 Jul 26RaisedFY26 revenue raised to $490-500M from $447-465M; FY26 AEBITDA raised to $66-78M from $43-57M · full year
24 Feb 26Raised2026 revenue $420M-$444M, adjusted EBITDA $30M-$45M · full year
4 Nov 25RaisedRevenue guidance raised from $367-373M to $372-376M; EBITDA guidance raised from $29-33M to $35-39M. · full year
6 Aug 25RaisedFY25 revenue raised to $367-373M from $365-375M; FY25 adjusted EBITDA unchanged at $29-33M · full year

CareDx, Inc. — questions

What guidance did CareDx, Inc. give?
On 2026-07-30: "FY26 revenue raised to $490-500M from $447-465M; FY26 AEBITDA raised to $66-78M from $43-57M"
When does CareDx, Inc. report earnings?
CareDx, Inc.'s next earnings report is expected on 2026-10-29.

Every figure on this page comes from CareDx, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.